- Home
- SELF vs CRVO Comparison
SELF vs CRVO Comparison
Compare SELF & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SELF | CRVO |
|---|---|---|
| Founded | 1983 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.3M | 47.7M |
| IPO Year | 1997 | 2011 |
Fundamental Metrics
Financial Performance| Metric | SELF | CRVO |
|---|---|---|
| Price | $5.19 | $4.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.50 |
| AVG Volume (30 Days) | 27.8K | ★ 89.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.57% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $12,530,280.00 | $9,737,974.00 |
| Revenue This Year | $1.59 | N/A |
| Revenue Next Year | $1.62 | N/A |
| P/E Ratio | $34.40 | ★ N/A |
| Revenue Growth | 2.79 | ★ 36.29 |
| 52 Week Low | $4.73 | $1.92 |
| 52 Week High | $5.83 | $16.50 |
Technical Indicators
Market Signals| Indicator | SELF | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 58.94 | 33.81 |
| Support Level | $5.12 | N/A |
| Resistance Level | $5.19 | $5.44 |
| Average True Range (ATR) | 0.08 | 0.45 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 63.67 | 26.36 |
Price Performance
Historical ComparisonAbout SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.